Vulnerability Description
An issue was discovered in Telindus Apsal 3.14.2022.235 b. The consultation permission is insecure.
CVSS Score
4.4
MEDIUM
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Telindus | Apsal | 3.14.2022.235_b |
References
- https://cds.thalesgroup.com/en/tcs-cert/CVE-2023-26099
- https://excellium-services.com/cert-xlm-advisory/CVE-2023-26099Third Party Advisory
- https://www.telindus.lu/fr/produits/apsalProduct
- https://excellium-services.com/cert-xlm-advisory/CVE-2023-26099Third Party Advisory
- https://www.telindus.lu/fr/produits/apsalProduct
FAQ
What is CVE-2023-26099?
CVE-2023-26099 is a vulnerability with a CVSS score of 4.4 (MEDIUM). An issue was discovered in Telindus Apsal 3.14.2022.235 b. The consultation permission is insecure.
How severe is CVE-2023-26099?
CVE-2023-26099 has been rated MEDIUM with a CVSS base score of 4.4/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-26099?
Check the references section above for vendor advisories and patch information. Affected products include: Telindus Apsal.